NCT03179904 2026-02-24TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast CancerMayo ClinicPhase 2 Active not recruiting17 enrolled 10 charts
NCT02270372 2018-05-17Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast CancerSeagen Inc.Phase 1 Completed22 enrolled